Cargando…
Designed BH3 Peptides with High Affinity and Specificity for Targeting Mcl-1 in Cells
[Image: see text] Mcl-1 is overexpressed in many cancers and can confer resistance to cell-death signaling in refractory disease. Molecules that specifically inhibit Mcl-1 hold potential for diagnosing and disrupting Mcl-1-dependent cell survival. We selected three peptides from a yeast-surface disp...
Autores principales: | Foight, Glenna Wink, Ryan, Jeremy A., Gullá, Stefano V., Letai, Anthony, Keating, Amy E. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Chemical
Society
2014
|
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4168798/ https://www.ncbi.nlm.nih.gov/pubmed/25052212 http://dx.doi.org/10.1021/cb500340w |
Ejemplares similares
-
The MCL-1 BH3 Helix is an Exclusive MCL-1 inhibitor and Apoptosis Sensitizer
por: Stewart, Michelle L., et al.
Publicado: (2010) -
Epistatic mutations in PUMA BH3 drive an alternate binding mode to potently and selectively inhibit anti-apoptotic Bfl-1
por: Jenson, Justin M, et al.
Publicado: (2017) -
Preferential targeting of MCL-1 by a hydrocarbon-stapled BIM BH3 peptide
por: Hadji, Abbas, et al.
Publicado: (2019) -
Stapled BH3 Peptides against MCL-1: Mechanism and Design Using Atomistic Simulations
por: Joseph, Thomas L., et al.
Publicado: (2012) -
Defining specificity and on-target activity of BH3-mimetics using engineered B-ALL cell lines
por: Koss, Brian, et al.
Publicado: (2016)